Affinage

Showing GTPBP4NOG1 is a alias.

GTPBP4

GTP-binding protein 4 · UniProt Q9BZE4

Length
634 aa
Mass
74.0 kDa
Annotated
2026-06-10
20 papers in source corpus 11 papers cited in narrative 11 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 7/7 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

GTPBP4 (NOG1) is a conserved nucleolar Obg-family GTPase that functions as a critical scaffold during 60S ribosomal subunit biogenesis (PMID:12788953, PMID:31909713). It associates with pre-60S precursor particles, co-sedimenting with 60S subunits and binding 60S precursor RNAs, and its loss blocks ITS2 cleavage and processing of large-subunit rRNAs, depleting free 60S particles (PMID:12788953). Within the assembling particle GTPBP4 acts as a molecular placeholder: its C-terminal tail occupies the polypeptide exit tunnel, and Drg1-ATPase-driven removal of Rlp24 extracts this tail, coordinating Rei1-mediated exit-tunnel quality control, Arx1 release, peptidyl transferase center maturation, and Yvh1-dependent Mrt4 release for stalk assembly (PMID:31909713). Conformational changes in the switch II region of its GTP-binding domain drive these maturation steps; a switch II mutant that retains GTP binding still arrests pre-60S assembly, causing accumulation of enlarged nucleolar pre-60S particles and degradation of nascent rRNA precursors (PMID:17785438, PMID:17443350). The Nog1–Nop7–Rlp24 complex shuttles between nucleolus and nucleoplasm, and TOR kinase governs this translocation in response to nutrients, coupling late ribosome maturation to nutrient status (PMID:16888624). In mammalian cancer cells GTPBP4 acquires additional regulatory roles: it binds and suppresses p53, with knockdown activating p53 signaling and apoptosis (PMID:29408813), and it bridges activated SUMO1 to PKM2 to induce PKM2 sumoylation and promote aerobic glycolysis (PMID:36116159). GTPBP4 also negatively regulates innate antiviral immunity by binding phosphorylated IRF3 through its GTP-binding domain, impairing IRF3 DNA binding and IFN-β transcription (PMID:37410776).

Mechanistic history

Synthesis pass · year-by-year structured walk · 11 steps
  1. 2003 High

    Established that GTPBP4/NOG1 is a nucleolar factor essential for 60S subunit biogenesis rather than a general translation factor, by localizing its function to a specific pre-60S maturation step.

    Evidence Co-sedimentation, RNA co-IP, RNAi knockdown and dominant-negative GTP-binding mutant in Trypanosoma brucei

    PMID:12788953

    Open questions at the time
    • Did not resolve where on the pre-60S particle Nog1 binds
    • Catalytic role of the GTPase domain not mechanistically defined
  2. 2006 High

    Showed that the Nog1 complex with Nop7 and Rlp24 physically shuttles between nucleolus and nucleoplasm and that this trafficking is the regulatory node controlled by TOR/nutrient signaling for late ribosome maturation.

    Evidence Reciprocal Co-IP, sucrose gradient sedimentation, rapamycin/nutrient-depletion epistasis and localization in S. cerevisiae

    PMID:16888624

    Open questions at the time
    • Molecular mechanism by which TOR controls Nog1 translocation not defined
    • Does not specify which maturation reactions occur in nucleolus vs nucleoplasm
  3. 2007 High

    Defined the switch II conformational cycle as the functional core: a switch II mutant that retains GTP binding still blocks pre-60S assembly, separating nucleotide binding from productive factor dissociation.

    Evidence Switch II point mutagenesis, nucleolar preribosome sedimentation and pre-rRNA processing analysis in mouse cells

    PMID:17785438

    Open questions at the time
    • Direct factors released by switch II movement not identified at this stage
    • GTP hydrolysis activity not quantified
  4. 2007 High

    Mapped the domain requirements of Nog1, showing pre-60S association is nucleotide-independent and that GTP-pocket integrity controls recruitment of downstream assembly factors.

    Evidence Site-directed mutagenesis of GTP-binding motifs, deletion analysis, isobaric-labeling MS of pre-60S composition and sedimentation in S. cerevisiae

    PMID:17443350

    Open questions at the time
    • Whether nucleotide state changes during the assembly cycle in vivo unresolved
    • Order of factor recruitment/release not established
  5. 2020 High

    Resolved Nog1 as a molecular placeholder whose C-terminal tail in the polypeptide exit tunnel coordinates sequential Drg1-ATPase and GTPase activities to orchestrate quality control and maturation of distant functional centers on the pre-60S.

    Evidence Cryo-EM, genetic epistasis, biochemical reconstitution and MS of pre-60S composition in S. cerevisiae

    PMID:31909713

    Open questions at the time
    • Timing and trigger of GTP hydrolysis during eviction not fully defined
    • Conservation of the precise placeholder mechanism in mammals not directly tested
  6. 2014 Medium

    Connected ribosome-biogenesis dosage of NOG1 to organismal physiology, linking it to growth, lifespan and fat metabolism through insulin/IGF signaling.

    Evidence RNAi, overexpression, GFP-fusion localization and lifespan/fat assays with insulin/IGF epistasis in C. elegans

    PMID:24552710

    Open questions at the time
    • Whether physiological effects are solely downstream of ribosome biogenesis unclear
    • Direct molecular link to insulin/IGF components not established
  7. 2016 Low

    Proposed an extraribosomal role in cell motility, linking GTPBP4 to colorectal metastasis through repression of RhoA-dependent actin remodeling.

    Evidence Knockdown and overexpression with motility/invasion assays and RhoA activity measurement in colorectal cancer cells

    PMID:27720713

    Open questions at the time
    • Single lab with limited mechanistic placement of GTPBP4 relative to RhoA
    • No direct physical interaction demonstrated
  8. 2018 Medium

    Identified GTPBP4 as a negative regulator of p53, providing a mechanistic basis for its pro-proliferative role in cancer.

    Evidence Co-IP, RNA-seq, stable knockdown and proliferation/apoptosis assays in gastric cancer cells

    PMID:29408813

    Open questions at the time
    • No in vitro reconstitution of the GTPBP4-p53 interaction
    • Domain mediating p53 binding not mapped
  9. 2022 Medium

    Established a non-ribosomal enzymatic-adaptor function: GTPBP4 bridges activated SUMO1 to PKM2, driving PKM2 sumoylation and aerobic glycolysis in hepatocellular carcinoma.

    Evidence Co-IP, sumoylation assays, subcellular fractionation, gain/loss-of-function and xenografts

    PMID:36116159

    Open questions at the time
    • Whether this linker activity requires the GTPase domain not tested
    • Generality beyond HCC unknown
  10. 2023 Medium

    Defined a role in innate immunity: GTPBP4 uses its GTP-binding domain to bind phospho-IRF3 and block its DNA binding, dampening type I interferon responses.

    Evidence Overexpression, knockout mice, Co-IP with phospho-IRF3, DNA-binding assay and in vivo VSV/HSV-1 challenge

    PMID:37410776

    Open questions at the time
    • Whether GTP hydrolysis is required for IRF3 inhibition not resolved
    • Relationship between nucleolar pool and cytoplasmic IRF3 regulation unclear
  11. 2025 Low

    Implicated GTPBP4-dependent ribosome biogenesis in endothelial-to-mesenchymal transition and myocardial fibrosis as a druggable target.

    Evidence Differential gene screening, knockdown in coronary artery endothelial cells, TGF-β1 EndMT model and in vivo fibrosis model

    PMID:40938540

    Open questions at the time
    • Limited mechanistic depth linking GTPBP4 to ribosome biogenesis in this context
    • Direct apigenin-GTPBP4 relationship not biochemically established

Open questions

Synthesis pass · forward-looking unresolved questions
  • How GTPBP4's conserved ribosome-assembly GTPase activity mechanistically relates to its mammalian extraribosomal functions (p53 suppression, PKM2 sumoylation, IRF3 inhibition) remains unresolved.
  • No structural model of mammalian GTPBP4 bound to p53, PKM2 or IRF3
  • Whether the GTP-binding domain and switch II cycle are used in non-ribosomal interactions untested
  • Whether moonlighting functions reflect cytoplasmic relocalization of a normally nucleolar protein unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003924 GTPase activity 4 GO:0060090 molecular adaptor activity 2 GO:0003723 RNA binding 1
Localization
GO:0005730 nucleolus 3 GO:0005634 nucleus 1 GO:0005654 nucleoplasm 1
Pathway
R-HSA-1852241 Organelle biogenesis and maintenance 2 R-HSA-8953854 Metabolism of RNA 2 R-HSA-168256 Immune System 1
Complex memberships
Nog1–Nop7–Rlp24 pre-60S complex

Evidence

Reading pass · 11 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2003 NOG1 (GTPBP4) is required for biogenesis of the 60S ribosomal subunit; it co-sediments with 60S ribosomal subunits (not monosomes), co-precipitates 60S precursor RNAs, and localizes to the nucleolus, indicating association with a pre-60S precursor particle. RNAi knockdown dramatically decreases free 60S particles and causes failure to cleave ITS2 from pre-rRNA. Overexpression of a GTP-binding-defective mutant causes a 60S biogenesis defect and reduced processing of large subunit rRNAs. Sucrose density gradient sedimentation, RNA co-immunoprecipitation, RNA interference knockdown, dominant-negative overexpression in Trypanosoma brucei The Journal of biological chemistry High 12788953
2006 In budding yeast, Nog1 forms a complex with 60S ribosomal proteins and pre-ribosomal proteins Nop7 and Rlp24. The Nog1 complex shuttles between the nucleolus and nucleoplasm for ribosome biogenesis. TOR kinase activity regulates late stages of ribosome maturation by controlling nucleolus-to-nucleoplasm translocation of this complex; nutrient depletion or TOR inactivation tethers the Nog1 complex to the nucleolus, arresting late-stage ribosome biogenesis. Subsequent loss of Nog1 and Nop7 leads to complete cessation of ribosome maturation. Co-immunoprecipitation, sucrose gradient sedimentation, rapamycin/nutrient-depletion epistasis, fluorescence localization in Saccharomyces cerevisiae The EMBO journal High 16888624
2007 In mouse cells, a point mutation restricting conformational flexibility of the switch II region of Nog1 (GTPBP4) creates a dominant-inhibitory phenotype: the mutant does not significantly affect GTP binding but disrupts productive pre-60S assembly, arrests cell proliferation, impairs processing of multiple pre-rRNA intermediates, causes degradation of nascent 5.8S/28S rRNA precursors, and leads to accumulation of enlarged pre-60S particles in the nucleolus, indicating that switch II conformational changes are critical for dissociation of preribosome-bound factors during intranucleolar maturation. Dominant-negative point mutagenesis (switch II region), sedimentation analysis of nucleolar preribosomes, pre-rRNA processing analysis in mouse cells Molecular and cellular biology High 17785438
2007 In S. cerevisiae, mutations in conserved GTP-binding pocket residues of Nog1 cause defects in cell growth and 60S ribosome assembly, but mutant proteins retain association with pre-60S particles. Association of Nog1 with pre-60S is independent of guanine nucleotide added to cell extracts. The N-terminal 126 amino acids are required for function; optimal pre-60S association requires sequences between amino acids 347–456. GTP-binding pocket mutations reduce levels of Nog1, Nop2, Nop15, and Tif6 in pre-60S particles. Site-directed mutagenesis of GTP-binding motifs, deletion analysis, isobaric labeling mass spectrometry of pre-60S particle composition, sucrose gradient sedimentation in S. cerevisiae Molecular genetics and genomics High 17443350
2020 The GTPase Nog1 coordinates assembly, maturation, and quality control of distant ribosomal functional centers on the pre-60S. Drg1-ATPase activity removes Rlp24 from Nog1 on the pre-60S; this extracts the C-terminal tail of Nog1 from the polypeptide exit tunnel (PET), enabling Rei1 to probe PET integrity and catalyze Arx1 release. Concomitantly, Nog1 eviction permits peptidyl transferase center maturation and allows Yvh1 to mediate Mrt4 release for stalk assembly. Thus Nog1 acts as a molecular placeholder coordinating sequential ATPase and GTPase activities during cytoplasmic pre-60S maturation. Cryo-EM structural analysis, genetic epistasis, biochemical reconstitution, mass spectrometry of pre-60S particle composition in S. cerevisiae eLife High 31909713
2014 In C. elegans, the nog-1 ortholog of GTPBP4 regulates growth, development, lifespan, and fat metabolism. GFP-tagged NOG-1 localizes to the nucleus, while aberrant NOG-1 concentrates in the nucleolus. Knockdown of nog-1 results in smaller brood size, slower growth, increased lifespan, and increased fat storage; overexpression decreases lifespan. Genetic evidence places nog-1 regulation of lifespan and fat storage via the insulin/IGF signaling pathway. RNAi knockdown, overexpression, GFP-fusion localization, lifespan and fat storage assays, genetic epistasis with insulin/IGF pathway in C. elegans Molecules and cells Medium 24552710
2018 GTPBP4 interacts with p53 in gastric cancer cells, as detected by co-immunoprecipitation. Stable knockdown of GTPBP4 activates p53 and p53-related signaling pathways, inhibits cell proliferation, and promotes apoptosis, placing GTPBP4 upstream of p53 in this cancer context. Co-immunoprecipitation, RNA-based high-throughput sequencing, lentiviral stable knockdown, proliferation and apoptosis assays in gastric cancer cells Cellular physiology and biochemistry Medium 29408813
2022 GTPBP4 promotes aerobic glycolysis in hepatocellular carcinoma by inducing dimeric PKM2 formation through protein sumoylation. Mechanistically, GTPBP4 facilitates SUMO1 activation by UBA2 and acts as a linker bridging activated SUMO1 and PKM2 to induce PKM2 sumoylation. SUMO-modified PKM2 then translocates from the cytoplasm to the nucleus, contributing to HCC progression via EMT and STAT3 signaling. Promoter methylation by DNMT3A regulates GTPBP4 expression. Gain- and loss-of-function studies (in vitro and in vivo), co-immunoprecipitation, protein sumoylation assays, subcellular fractionation, mouse xenograft models Redox biology Medium 36116159
2016 GTPBP4 promotes colorectal carcinoma metastasis by disrupting the actin cytoskeleton through repression of RhoA signaling activity, as demonstrated by knockdown (which impedes cell motility) and ectopic overexpression (which enhances cell motility and metastasis). Knockdown and ectopic overexpression in colorectal cancer cells, cell motility/invasion assays, RhoA activity measurement Biochemical and biophysical research communications Low 27720713
2023 NOG1 (GTPBP4) negatively regulates type I interferon production by interacting with phosphorylated IRF3 and impairing its DNA-binding activity, thereby downregulating IFN-β transcription and downstream ISG expression. NOG1 overexpression inhibits viral RNA- and DNA-mediated IFN signaling; NOG1 deficiency promotes antiviral innate immune responses and resistance to VSV and HSV-1. The GTP-binding domain of NOG1 is required for this function. Overexpression and knockout (NOG1-deficient mice), co-immunoprecipitation with phospho-IRF3, DNA-binding activity assay, in vivo viral challenge (VSV, HSV-1), IFN-β ELISA PLoS pathogens Medium 37410776
2025 GTPBP4 plays a role in ribosome biogenesis in coronary artery endothelial cells and was identified as a key target gene regulating ribosome biogenesis during myocardial fibrosis progression. Downregulation of GTPBP4 by apigenin suppressed EndMT and alleviated myocardial fibrosis in vitro and in vivo. Differential gene screening, knockdown in human coronary artery endothelial cells, in vitro EndMT model (TGF-β1-induced), in vivo animal fibrosis model Human cell Low 40938540

Source papers

Stage 0 corpus · 20 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2003 The NOG1 GTP-binding protein is required for biogenesis of the 60 S ribosomal subunit. The Journal of biological chemistry 79 12788953
2022 GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox biology 67 36116159
2006 TOR regulates late steps of ribosome maturation in the nucleoplasm via Nog1 in response to nutrients. The EMBO journal 45 16888624
2020 The GTPase Nog1 co-ordinates the assembly, maturation and quality control of distant ribosomal functional centers. eLife 35 31909713
2017 The small GTPase, nucleolar GTP-binding protein 1 (NOG1), has a novel role in plant innate immunity. Scientific reports 29 28835689
2007 In vivo functional characterization of the Saccharomyces cerevisiae 60S biogenesis GTPase Nog1. Molecular genetics and genomics : MGG 28 17443350
2016 Up-regulation of GTPBP4 in colorectal carcinoma is responsible for tumor metastasis. Biochemical and biophysical research communications 18 27720713
2014 Nucleolar GTPase NOG-1 regulates development, fat storage, and longevity through insulin/IGF signaling in C. elegans. Molecules and cells 18 24552710
2007 Restricting conformational flexibility of the switch II region creates a dominant-inhibitory phenotype in Obg GTPase Nog1. Molecular and cellular biology 18 17785438
2018 GTPBP4 Promotes Gastric Cancer Progression via Regulating P53 Activity. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 17 29408813
2018 Nucleolar GTP-Binding Protein 1-2 (NOG1-2) Interacts with Jasmonate-ZIMDomain Protein 9 (JAZ9) to Regulate Stomatal Aperture during Plant Immunity. International journal of molecular sciences 16 29966336
2021 Upregulation of GTPBP4 Promotes the Proliferation of Liver Cancer Cells. Journal of oncology 12 34712323
2021 LncRNA FGD5-AS1 functions as an oncogene to upregulate GTPBP4 expression by sponging miR-873-5p in hepatocellular carcinoma. European journal of histochemistry : EJH 10 34783233
2020 Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas. BioMed research international 9 33134380
2023 NOG1 downregulates type I interferon production by targeting phosphorylated interferon regulatory factor 3. PLoS pathogens 6 37410776
2022 GTPBP4: A New Therapeutic Target Gene Promotes Tumor Progression in Non-Small Cell Lung Cancer via EMT. Journal of oncology 6 36405249
2025 Decoding the Molecular Landscape of Prepubertal Oocyte Maturation: GTPBP4 as a Key Driver of In Vitro Developmental Competence. Cell proliferation 5 40017443
2022 Integrated Analysis of Genomic and Transcriptomic Profiles Identified the Role of GTP Binding Protein-4 (GTPBP4) in Breast Cancer. Frontiers in pharmacology 3 35784753
2022 The grain yield regulator NOG1 plays a dual role in latitudinal adaptation and cold tolerance during rice domestication. Frontiers in genetics 2 36437935
2025 Apigenin inhibits endothelial-to-mesenchymal transition of coronary artery endothelial cells and myocardial fibrosis by regulating ribosome biogenesis through GTPBP4 modulation. Human cell 0 40938540

Missed literature

Know a paper Affinage missed for GTPBP4? Flag it for the maintainers and the community.

No submissions yet.